抗癌消水膏治疗恶性胸腔积液的临床研究  

Clinical Trial of Kangaixiaoshui Cream for Treating Malignant Hydrothorax

作　　者：贾立群[1] 李佩文[1] 谭煌英[1] 程志强[1] 于莉莉[1] 万冬桂[1] 蔡光荣[1] 

机构地区：[1]中日友好医院肿瘤科,北京100029

出　　处：《北京中医药大学学报》2002年第4期63-65,共3页Journal of Beijing University of Traditional Chinese Medicine

摘　　要：探讨中药外敷法治疗恶性胸腔积液的临床疗效和特点。用黄芪、桂枝等研制成抗癌消水膏外敷恶性胸水患者的胸壁 ,与腔内免疫治疗法比较 ,对体力状况 (PS) >2的肿瘤病人并发恶性胸水者进行随机分组各 2 5例。观察各组病人胸水、胸痛、生活质量的改善状况及胸水癌细胞核抗原(PCNA)弱阳性率的表达。结果提示抗癌消水膏治疗恶性胸水有效率为 5 6% ,优于腔内免疫治疗组 (4 8% )。特别是对胸痛、病人生活质量有明显改善作用 ,并可抑制胸水中癌细胞增殖。The clinical efficacy of Kangaixiaoshui Cream (KC) for treating malignant hydrothorax was investigated. KC, a TCM preparation for external application was applied externally on the chest wall of the patients with malignant hydrothorax, and the patients in the control group were treated by the intrapleural immunotherapy (IIT). 50 Neoplastic patients with malignant hydrothorax (PS >2) were divided into KC group and IIT group, and comparison was made between the 2 groups concerning the pleural effusion, chest pain, quality of life and the weak positive expression rates of PCNA. The results showed that the effective rate of KC for treating malignant hydrothorax was 56%, higher than that of IIT (48%); and KC could markedly relieve chest pain and improve the quality of life, and inhibit the proliferation of tumor cells in hydrothorax.

关 键 词：抗癌消水膏 治疗 恶性胸腔积液 临床研究 恶性肿瘤 

分 类 号：R273.06[医药卫生—中西医结合] R286.91[医药卫生—中医肿瘤科]